| Chronic hepatitis C virus (HCV) infection (genotypes 1–6) |
| Used in combination with other antivirals (e.g., Ledipasvir, Velpatasvir) |
| Patients with compensated cirrhosis |
| Post-liver transplant HCV recurrence |
Tablet
Sofosbuvir is a direct-acting antiviral agent used in the treatment of chronic hepatitis C virus (HCV) infection. It is a nucleotide analog inhibitor of the HCV NS5B RNA-dependent RNA polymerase, essential for viral replication.
| Speciality | Hepatology | Infectious Diseases | Internal Medicine |
|---|---|
| Tags | Hepatitis C | Antiviral | NS5B Polymerase Inhibitor | Direct-acting Antiviral |
| Strength |
|
| Packing Size |
|
All product details on this website are for reference and informational purposes only and
are not directed at patients or consumers.
As a contract manufacturer,
DM Pharma Pvt Ltd is not responsible for the marketing or end use of these products and disclaims all
liability arising from reliance on this information.
Please consult a healthcare professional before
using any medicinal product.